Comparison of contrast-enhanced MR angiography to intraarterial digital subtraction angiography for evaluation of peripheral arterial occlusive disease: Results of a phase III multicenter trial

Journal of Magnetic Resonance Imaging

Volumn 31, Issue 6, 2010, Pages 1402-1410

  Bui, Bao T ^a   Miller, Stephan ^b   Mildenberger, Peter ^c   Sam II, Albert ^d   Sheng, Rubin ^e  

^a CENTRE HOSPITALIER UNIVERSITAIRE DE SHERBROOKE   (Canada)

^b UNIVERSITY OF TÜBINGEN   (Germany)

^c UNIVERSITY MEDICAL CENTER MAINZ   (Germany)

^d Vascular Surgery Associates   (United States)

^e GE HEALTHCARE   (United States)

Author keywords

Contrast media; Gadodiamide; Intraarterial digital subtraction angiography; Magnetic resonance angiography; Peripheral arterial occlusive disease

Indexed keywords

GADODIAMIDE; CONTRAST MEDIUM; GADOLINIUM PENTETATE;

ADULT; AGED; ARTERY OCCLUSION; ARTICLE; CLINICAL TRIAL; CONTRAST ENHANCEMENT; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIARRHEA; DIGITAL SUBTRACTION ANGIOGRAPHY; DRUG EFFICACY; FEMALE; HUMAN; IMAGE QUALITY; INJECTION SITE DERMATITIS; MAGNETIC RESONANCE ANGIOGRAPHY; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; NAUSEA; NUCLEAR MAGNETIC RESONANCE SCANNER; PERIPHERAL OCCLUSIVE ARTERY DISEASE; PHASE 3 CLINICAL TRIAL; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; ARTERIAL OCCLUSIVE DISEASES; ELECTROCARDIOGRAPHY; MIDDLE AGED; PATHOLOGY; PERIPHERAL VASCULAR DISEASES; PROCEDURES; REPRODUCIBILITY; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; ANGIOGRAPHY, DIGITAL SUBTRACTION; ARTERIAL OCCLUSIVE DISEASES; CONTRAST MEDIA; ELECTROCARDIOGRAPHY; FEMALE; GADOLINIUM DTPA; HUMANS; MAGNETIC RESONANCE ANGIOGRAPHY; MALE; MIDDLE AGED; PERIPHERAL VASCULAR DISEASES; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY;

EID: 77952864516     PISSN: 10531807     EISSN: 15222586     Source Type: Journal    
DOI: 10.1002/jmri.22086     Document Type: Article

References (21)

1. Yucel EK, Kaufman JA, Geller SC, Waltman AC. Atherosclerotic occlusive disease of the lower extremity: prospective evaluation with two-dimensional time-of-flight MR angiography. Radiology 1993;187:637-1636
2. Prince MR, Yucel EK, Kaufman JA, et al. Dynamic gadolinium-enhanced three-dimensional abdominal MR arteriography. J Magn Reson Imaging 1993;3:877-881
3. Hany TF, Debatin JF, Leung DA, et al. Evaluation of the aortoiliac and renal arteries: comparison of breath-hold, contrastenhanced, three-dimensional MR angiography with conventional catheter angiography. Radiology 1997;204:357-362.
4. Meaney JFM, Ridgway JP, Chakraverty S, et al. Stepping-table gadolinium-enhanced digital subtraction MR angiography of the aorta and lower extremity arteries: preliminary experience. Radiology 1999;211:59-67. (Pubitemid 29161734)
5. Ruehm SG, Hany TF, Pfammatter T, et al. Diagnostic performance of three-dimensional contrast-enhanced MR angiography. AJR Am J Roentgenol 2000;174:1127-1135.
6. Huegli HW, Thalhammer C, Jacob AL, et al. Intra-arterial MR-angiography on an open-bore MR-scanner compared to digital-subtraction angiography of the infra-popliteal runoff in patients with peripheral arterial occlusive disease. Eur J Radiol 2008;66:519-525. (Pubitemid 351763860)
7. Kreitner K-F, Kalden P, Neufang A, et al. Diabetes and peripheral arterial occlusive disease: prospective comparison of contrastenhanced three-dimensional MRA angiography with conventional digital subtraction angiography. AJR Am J Roentgenol 2000;174:171-179. (Pubitemid 30030230)
8. Lapeyre M, Kobeiter H, Desgranges P, et al. Assessment of critical limb ischemia in patients with diabetes: comparison of MR angiography and digital subtraction angiography. AJR Am J Roentgenol 2005;185:1641-1650.
9. Meissner OA, Verrel F, Tató F, et al. Magnetic resonance angiography in the follow-up of distal lower-extremity bypass surgery: comparison with duplex ultrasound and digital subtraction angiography. J Vasc Intern Radiol 2004;15:1269-1277. (Pubitemid 39487858)
10. Eiberg JP, Lundorf E, Thomsen C, Schroeder TV. Peripheral vascular surgery and magnetic resonance arteriography-a review. Eur J Endovasc Surg 2001;22:396-402. (Pubitemid 33085548)
11. Nelemans PJ, Leiner T, de Vet HCW, van Engelshoven JMA. Peripheral arterial disease: meta-analysis of the diagnostic performance of MR angiography. Radiology 2000;217:105-114. (Pubitemid 33097585)
12. Dong Q, Schoenberg SO, Carlos RC, et al. Diagnosis of renal vascular disease with MR angiography. Radiographics 1999;19:1535-1554.
13. Rapp JH, Wolff SD, Quinn SF, et al. Aortoiliac occlusive disease in patients with known or suspected peripheral vascular disease: safety and efficacy of gadofosveset-enhanced MR angiography-multicenter comparative phase III study. Radiology 2005;236:71-78.
14. Prince MR, Grist TM,Debatin JF (eds.). Renal arteries. In: 3D contrast MR angiography, 2nd ed.New York:Springer;1999:89-105.
15. Leung DA, Hagspiel KD, Angle JF, et al. MR angiography of the renal arteries. Radiol Clin N Am 2002;40:847-865.
16. Gilfeather M, Yooun H-C, Siegelmann ES, et al. Renal artery stenosis: evaluation with conventional angiography versus gadolinium-enhanced MR angiography. Radiology 1999;210:367-372. (Pubitemid 29055302)
17. Hirsch AT, Haskal ZJ, Hertzer NR, et al. Peripheral arterial disease: ACC/AHA 2005 guidelines for the management of patients with peripheral arterial disease (lower extremity, renal, mesenteric, and abdominal aortic): a collaborative report from the American Association for Vascular Surgery/Society for Vascular Surgery, Society for Cardiovascular Angiography and Interventions, Society for Vascular Medicine and Biology, Society of Interventional Radiology, and the ACC/AHA Task Force on Practice Guidelines (Writing Committee to Develop Guidelines for the Management of Patients With Peripheral Arterial Disease). J Am Coll Cardiol 2006;47:1239-1312.
18. Prince MR, Zhang HL, Morris M, et al. Incidence of nephrogenic systemic fibrosis at two large medical centers. Radiology 2008;248:807-816.
19. Boyd AS, Zic JA, Abraham JL. Gadolinium deposition in nephrogenic fibrosing dermopathy. J Am Acad Dermatol 2007;56:27-30. (Pubitemid 44969309)
20. Broome DR, Girguis MS, Baron PW, Cottrell AC, Klellin I, Kirk GA. Gadodiamide-associated nephrogenic systemic fibrosis: why radiologists should be concerned. Am J Roentgenol 2007;188:586-592.
21. Deo A, Fogel M, Cowper SE. Nephrogenic systemic fibrosis: a population study examining the relationship of disease development to gadolinium exposure. Clin J Am Soc Nephrol 2007;2:264-267.